Baxter International Investors Pursuing Class Action Lawsuit

Recently, investors who suffered financial losses from Baxter International, Inc. (NYSE: BAX) are encouraged to reach out to Levi & Korsinsky, LLP. The firm has initiated a class action lawsuit designed to address grievances stemming from alleged securities fraud committed by the company. This lawsuit targets investors impacted between February 23, 2022, and July 30, 2025.

Background of the Case

The motive behind this class action stems from multiple claims regarding Baxter's recently launched product, the Novum LVP. Allegations suggest that the device has been associated with significant defects, leading to various malfunctions such as underinfusion, overinfusion, and even total failure in fluid delivery. These issues have posed serious health risks to patients, including potential injuries and fatalities.

The complaint asserts that Baxter was notified of various device malfunctions, along with reports of injuries and deaths resulting from these defects. Despite this knowledge, Baxter's responses—such as issuing customer alerts—were reportedly insufficient, and the defects persisted, leading to ongoing risks for patients. According to the information, Baxter's statements concerning the safety and effectiveness of the Novum LVP were misleading, which heightened the risk that existing units in the market would need to be withdrawn from service, ultimately halting all new sales of the product.

Class Action Details

For investors who wish to participate in this class action, the deadline to request the court appoint them as lead plaintiff is December 15, 2025. Involvement in this suit does not require those interested to serve as lead plaintiff to benefit from any potential recovery from the case. The firm emphasizes that there are no out-of-pocket fees for class members wishing to participate.

If a loss occurred during the aforementioned time frame, affected individuals should consider reaching out to Levi & Korsinsky for further guidance. They may contact the firm directly via email or telephone, as provided in notices circulating about the case. Contact points include the office of Joseph E. Levi, Esq., who leads the team handling these matters.

Why Choose Levi & Korsinsky?

Levi & Korsinsky boasts a robust history in successfully representing shareholders, recovering hundreds of millions in settlements over the past two decades. The firm prides itself in specializing in complex securities litigation, employing a dedicated team of over 70 professionals to support their clients. Consistently recognized by ISS Securities Class Action Services over the last seven years, they have established their place as a top securities litigation firm in the United States.

For those affected by Baxter's recent incidents, this class action presents an opportunity to seek justice and potentially recover losses inflicted by what is alleged to be deceptive practices. As the situation unfolds, it remains imperative for investors to stay informed and act promptly in securing their legal rights.

For more information about this class action, visit Levi & Korsinsky's website or reach out to their office to capture your eligibility in this potential claims process.

Contact Information
Joseph E. Levi, Esq.
Levi & Korsinsky, LLP
33 Whitehall Street, 27th Floor
New York, NY 10004
Email: [email protected]
Phone: (212) 363-7500